An accelerated pathway for targeted cancer therapies

Mark McClellan, Joshua Benner, Richard Schilsky, David Epstein, Ray Woosley, Stephen Friend, David Sidransky, Cindy Geoghegan, David Kessler

Research output: Contribution to journal › Article

Abstract

A well-defined pathway for the accelerated development and approval of targeted cancer therapies and companion diagnostics would reduce uncertainty, improve efficiency in development and provide an effective incentive for developers.

Original languageEnglish (US)
Pages (from-to)79-80
Number of pages2
JournalNature Reviews Drug Discovery
Volume10
Issue number2
DOIs
StatePublished - Feb 2011

Fingerprint

Uncertainty
Motivation
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology

Cite this

McClellan, M., Benner, J., Schilsky, R., Epstein, D., Woosley, R., Friend, S., ... Kessler, D. (2011). An accelerated pathway for targeted cancer therapies. Nature Reviews Drug Discovery, 10(2), 79-80. https://doi.org/10.1038/nrd3360

An accelerated pathway for targeted cancer therapies. / McClellan, Mark; Benner, Joshua; Schilsky, Richard; Epstein, David; Woosley, Ray; Friend, Stephen; Sidransky, David; Geoghegan, Cindy; Kessler, David.

In: Nature Reviews Drug Discovery, Vol. 10, No. 2, 02.2011, p. 79-80.

Research output: Contribution to journal › Article

McClellan, M, Benner, J, Schilsky, R, Epstein, D, Woosley, R, Friend, S, Sidransky, D, Geoghegan, C & Kessler, D 2011, 'An accelerated pathway for targeted cancer therapies', Nature Reviews Drug Discovery, vol. 10, no. 2, pp. 79-80. https://doi.org/10.1038/nrd3360
McClellan M, Benner J, Schilsky R, Epstein D, Woosley R, Friend S et al. An accelerated pathway for targeted cancer therapies. Nature Reviews Drug Discovery. 2011 Feb;10(2):79-80. https://doi.org/10.1038/nrd3360
McClellan, Mark ; Benner, Joshua ; Schilsky, Richard ; Epstein, David ; Woosley, Ray ; Friend, Stephen ; Sidransky, David ; Geoghegan, Cindy ; Kessler, David. / An accelerated pathway for targeted cancer therapies. In: Nature Reviews Drug Discovery. 2011 ; Vol. 10, No. 2. pp. 79-80.
@article{5eae9572a9f14cfba7c07a93f7577dc2,
title = "An accelerated pathway for targeted cancer therapies",
abstract = "A well-defined pathway for the accelerated development and approval of targeted cancer therapies and companion diagnostics would reduce uncertainty, improve efficiency in development and provide an effective incentive for developers.",
author = "Mark McClellan and Joshua Benner and Richard Schilsky and David Epstein and Ray Woosley and Stephen Friend and David Sidransky and Cindy Geoghegan and David Kessler",
year = "2011",
month = "2",
doi = "10.1038/nrd3360",
language = "English (US)",
volume = "10",
pages = "79--80",
journal = "Nature Reviews Drug Discovery",
issn = "1474-1776",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - An accelerated pathway for targeted cancer therapies

AU - McClellan, Mark

AU - Benner, Joshua

AU - Schilsky, Richard

AU - Epstein, David

AU - Woosley, Ray

AU - Friend, Stephen

AU - Sidransky, David

AU - Geoghegan, Cindy

AU - Kessler, David

PY - 2011/2

Y1 - 2011/2

N2 - A well-defined pathway for the accelerated development and approval of targeted cancer therapies and companion diagnostics would reduce uncertainty, improve efficiency in development and provide an effective incentive for developers.

AB - A well-defined pathway for the accelerated development and approval of targeted cancer therapies and companion diagnostics would reduce uncertainty, improve efficiency in development and provide an effective incentive for developers.

UR - http://www.scopus.com/inward/record.url?scp=79551609869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551609869&partnerID=8YFLogxK

U2 - 10.1038/nrd3360

DO - 10.1038/nrd3360

M3 - Article

C2 - 21283090

AN - SCOPUS:79551609869

VL - 10

SP - 79

EP - 80

JO - Nature Reviews Drug Discovery

JF - Nature Reviews Drug Discovery

SN - 1474-1776

IS - 2

ER -

Access to Document